PAPER Rahimi-Balaei M, Buchok M, Vihko P, Parkinson FE, Marzban H
SEARCH RESULTS
4078 RESULTS
PAPER Visanji NP, Lang AE, Kovacs GG
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities.
Transl Neurodegener. 2019;8:28. Epub 2019 Sep 4 PubMed: 31508228PAPER Albus A, Jördens M, Möller M, Dodel R
Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases.
Front Immunol. 2019;10:2033. Epub 2019 Aug 27 PubMed: 31507618PAPER Cariulo C, Martufi P, Verani M, Azzollini L, Bruni G, Weiss A, Deguire SM, Lashuel HA, Scaricamazza E, Sancesario GM, Schirinzi T, Mercuri NB, Sancesario G, Caricasole A, Petricca L
Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay.
Front Neurosci. 2019;13:889. Epub 2019 Aug 22 PubMed: 31507364PAPER
Erratum: Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process [Corrigendum].
Int J Nanomedicine. 2019;14:6733-6734. Epub 2019 Aug 23 PubMed: 31507317PAPER Fabian P, Stapor K, Banach M, Ptak-Kaczor M, Konieczny L, Roterman I
Different Synergy in Amyloids and Biologically Active Forms of Proteins.
Int J Mol Sci. 2019 Sep 9;20(18) PubMed: 31505841PAPER Hwang J, Estick CM, Ikonne US, Butler D, Pait MC, Elliott LH, Ruiz S, Smith K, Rentschler KM, Mundell C, Almeida MF, Stumbling Bear N, Locklear JP, Abumohsen Y, Ivey CM, Farizatto KL, Bahr BA
The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.
Int J Mol Sci. 2019 Sep 9;20(18) PubMed: 31505809PAPER Fogarty MJ, Mu EW, Lavidis NA, Noakes PG, Bellingham MC
Size-Dependent Vulnerability of Lumbar Motor Neuron Dendritic Degeneration in SOD1G93A Mice.
Anat Rec (Hoboken). 2019 Sep 11; PubMed: 31509351PAPER Ho WY, Chang JC, Tyan SH, Yen YC, Lim K, Tan BS, Ong J, Tucker-Kellogg G, Wong P, Koo E, Ling SC
FUS-mediated dysregulation of Sema5a, an autism-related gene, in FUS mice with hippocampus-dependent cognitive deficits.
Hum Mol Genet. 2019 Nov 15;28(22):3777-3791. PubMed: 31509188PAPER Ralli M, Lambiase A, Artico M, de Vincentiis M, Greco A
Amyotrophic Lateral Sclerosis: Autoimmune Pathogenic Mechanisms, Clinical Features, and Therapeutic Perspectives.
Isr Med Assoc J. 2019 Jul;21(7):438-443. PubMed: 31507117PAPER Takahashi S, Morimoto S, Okano H
[Ropinirole Hydrochloride, a Candidate Drug for ALS Treatment].
Brain Nerve. 2019 Sep;71(9):943-952. PubMed: 31506396PAPER Vander Zanden CM, Wampler L, Bowers I, Watkins EB, Majewski J, Chi EY
Fibrillar and Nonfibrillar Amyloid Beta Structures Drive Two Modes of Membrane-Mediated Toxicity.
Langmuir. 2019 Dec 3;35(48):16024-16036. Epub 2019 Sep 26 PubMed: 31509701PAPER Horvath A, Kiss M, Szucs A, Kamondi A
Precuneus-Dominant Degeneration of Parietal Lobe Is at Risk of Epilepsy in Mild Alzheimer's Disease.
Front Neurol. 2019;10:878. Epub 2019 Aug 22 PubMed: 31507508PAPER Stanzani Maserati M, Mitolo M, Medici F, D'Onofrio R, Oppi F, Poda R, De Matteis M, Tonon C, Lodi R, Liguori R, Capellari S
Color Choice Preference in Cognitively Impaired Patients: A Look Inside Alzheimer's Disease Through the Use of Lüscher Color Diagnostic.
Front Psychol. 2019;10:1951. Epub 2019 Aug 27 PubMed: 31507498PAPER Cenini G, Voos W
Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update.
Front Pharmacol. 2019;10:902. Epub 2019 Aug 23 PubMed: 31507410Current Filters
- Date Range : Sep 2019 to Dec 2019 x